DrugCite
Search

TORSEMIDE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Torsemide Adverse Events Reported to the FDA Over Time

How are Torsemide adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Torsemide, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Torsemide is flagged as the suspect drug causing the adverse event.

Most Common Torsemide Adverse Events Reported to the FDA

What are the most common Torsemide adverse events reported to the FDA?

Renal Failure Acute
206 (3.72%)
Drug Interaction
145 (2.62%)
Hypotension
116 (2.1%)
Dehydration
86 (1.55%)
Vomiting
81 (1.46%)
Dizziness
69 (1.25%)
Hyperkalaemia
68 (1.23%)
Dyspnoea
66 (1.19%)
Hypokalaemia
58 (1.05%)
Hyponatraemia
58 (1.05%)
Diarrhoea
57 (1.03%)
Show More Show More
Nausea
55 (.99%)
Syncope
50 (.9%)
Blood Creatinine Increased
49 (.89%)
Cardiac Failure
48 (.87%)
Renal Failure
48 (.87%)
Fall
47 (.85%)
Blood Urea Increased
45 (.81%)
Atrial Fibrillation
43 (.78%)
Bradycardia
42 (.76%)
Condition Aggravated
41 (.74%)
General Physical Health Deteriorati...
41 (.74%)
Pneumonia
39 (.7%)
Orthostatic Hypotension
38 (.69%)
International Normalised Ratio Incr...
36 (.65%)
Loss Of Consciousness
35 (.63%)
Gamma-glutamyltransferase Increased
33 (.6%)
Renal Failure Chronic
33 (.6%)
Metabolic Acidosis
32 (.58%)
Alanine Aminotransferase Increased
31 (.56%)
Pleural Effusion
30 (.54%)
Thrombocytopenia
30 (.54%)
Fatigue
29 (.52%)
Somnolence
28 (.51%)
Asthenia
27 (.49%)
Abdominal Pain Upper
26 (.47%)
Aspartate Aminotransferase Increase...
26 (.47%)
Deep Vein Thrombosis
26 (.47%)
Suicide Attempt
26 (.47%)
Blood Pressure Increased
25 (.45%)
Haemoglobin Decreased
25 (.45%)
Pulmonary Embolism
25 (.45%)
Cerebrovascular Accident
24 (.43%)
Confusional State
24 (.43%)
Drug Ineffective
24 (.43%)
Left Ventricular Failure
24 (.43%)
Pruritus
24 (.43%)
Pulmonary Congestion
24 (.43%)
Stevens-johnson Syndrome
24 (.43%)
Cardiac Arrest
23 (.42%)
Depressed Level Of Consciousness
23 (.42%)
Acute Prerenal Failure
22 (.4%)
Hypertensive Crisis
22 (.4%)
Infection
21 (.38%)
Oedema Peripheral
21 (.38%)
Rhabdomyolysis
21 (.38%)
Angina Pectoris
20 (.36%)
Bundle Branch Block Left
20 (.36%)
Prothrombin Time Prolonged
19 (.34%)
Anaemia
18 (.33%)
Blood Glucose Increased
18 (.33%)
Cutaneous Lupus Erythematosus
18 (.33%)
Overdose
18 (.33%)
Pulmonary Oedema
18 (.33%)
Malaise
17 (.31%)
Pancreatitis Acute
17 (.31%)
Sepsis
17 (.31%)
Urinary Tract Infection
17 (.31%)
Blood Potassium Increased
16 (.29%)
Completed Suicide
16 (.29%)
Fluid Retention
16 (.29%)
Hypertension
16 (.29%)
Pancytopenia
16 (.29%)
Abdominal Pain
15 (.27%)
Agitation
15 (.27%)
Disorientation
15 (.27%)
Drug Toxicity
15 (.27%)
Weight Decreased
15 (.27%)
Blood Albumin Decreased
14 (.25%)
Blood Alkaline Phosphatase Increase...
14 (.25%)
Drug Level Increased
14 (.25%)
Heart Rate Decreased
14 (.25%)
Liver Injury
14 (.25%)
Medication Error
14 (.25%)
Pyrexia
14 (.25%)
Weight Increased
14 (.25%)
Abortion Induced
13 (.23%)
Ascites
13 (.23%)
Blood Bilirubin Increased
13 (.23%)
Gastrointestinal Haemorrhage
13 (.23%)
Haemodialysis
13 (.23%)
Irritable Bowel Syndrome
13 (.23%)
Renal Impairment
13 (.23%)
Respiratory Failure
13 (.23%)
Small Intestinal Perforation
13 (.23%)
Tachycardia
13 (.23%)
Toxic Epidermal Necrolysis
13 (.23%)
Transaminases Increased
13 (.23%)
Arthralgia
12 (.22%)
Azotaemia
12 (.22%)
Decreased Appetite
12 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Torsemide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Torsemide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Torsemide

What are the most common Torsemide adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Torsemide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Torsemide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Torsemide According to Those Reporting Adverse Events

Why are people taking Torsemide, according to those reporting adverse events to the FDA?

Hypertension
798
Drug Use For Unknown Indication
391
Product Used For Unknown Indication
347
Cardiac Failure
259
Oedema
164
Cardiac Failure Congestive
89
Show More Show More
Diuretic Therapy
84
Renal Failure
50
Cardiac Failure Chronic
50
Fluid Retention
43
Oedema Peripheral
37
Essential Hypertension
35
Renal Failure Chronic
35
Glomerulonephritis Membranous
26
Polyuria
24
Coronary Artery Disease
23
Ascites
19
Renal Impairment
15
Suicide Attempt
13
Oedema Due To Cardiac Disease
13
Prophylaxis
13
Hypertensive Heart Disease
12
Aortic Valve Replacement
11
Swelling
10
Right Ventricular Failure
9
Atrial Fibrillation
8
Myocardial Ischaemia
8
Ill-defined Disorder
8
Cardiac Disorder
7
Acute Myocardial Infarction
7
Accidental Exposure
7
Hepatic Cirrhosis
6
Face Oedema
6
Fluid Overload
6
Hyponatraemia
6
Pulmonary Hypertension
5
Renal Failure Acute
5
Pulmonary Arterial Hypertension
5
Fluid Imbalance
5
Blood Pressure
5
Myocardial Infarction
4
Diabetic Nephropathy
4
Fatigue
4
Joint Swelling
4
Hypertonia
4
Pleural Effusion
4
Portal Hypertension
3
Cardiac Failure Acute
3
Anuria
3
Congestive Cardiomyopathy
3
Blood Urea Increased
3

Drug Labels

LabelLabelerEffective
TorsemideUDL Laboratories, Inc13-OCT-06
TorsemidePar Pharmaceutical Inc22-DEC-09
TorsemideSUN PHARMACEUTICAL INDUSTRIES LIMITED15-MAY-10
TorsemideAmerican Regent, Inc.18-OCT-10
Torsemide General Injectables and Vaccines, Inc.14-FEB-12
Torsemide General Injectables and Vaccines, Inc.14-FEB-12
TorsemideCardinal Health27-MAR-12
TorsemideAmerican Health Packaging03-APR-12
TorsemideNCS HealthCare of KY, Inc dba Vangard Labs10-MAY-12
TorsemideRoxane Laboratories, Inc20-JUN-12
DemadexMeda Pharmaceuticals Inc.21-AUG-12
TorsemidePhysicians Total Care, Inc.11-SEP-12
TorsemideQualitest Pharmaceuticals13-SEP-12
TorsemideBryant Ranch Prepack12-OCT-12
TorsemideAurobindo Pharma Limited16-OCT-12
TorsemidePliva, Inc21-NOV-12
TorsemideApotex Corp.07-JAN-13
TorsemideBryant Ranch Prepack16-JAN-13
TorsemideCamber Pharmaceuticals, Inc.19-JAN-13
TorsemideGreenstone LLC21-JAN-13

Torsemide Case Reports

What Torsemide safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Torsemide. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Torsemide.